Inhibition of carnitine-acyl transferase I by oxfenicine studied in vivo with [11C]-labeled fatty acids

Nuclear Medicine and Biology

Volumn 32, Issue 5, 2005, Pages 495-503

  Angsten, Gertrud ^a   Valind, Sven ^b,c   Takalo, Reijo ^b,c   Neu, Henrik ^b   Meurling, Staffan ^a   Långström, Bengt ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carnitine; Fatty acid oxidation; Myocardial metabolism; Oxfenicine; PET

Indexed keywords

ACYL COENZYME A; CARBON 11; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; DODECANOIC ACID C 11; FATTY ACID DERIVATIVE; LACTIC ACID; OCTANOIC ACID C 11; OXFENICINE; PALMITIC ACID; PALMITIC ACID C 11; TETRADECANOIC ACID C 11; TRACER; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ESTERIFICATION; HEART; HEART MUSCLE; IN VIVO STUDY; ISOTOPE LABELING; MITOCHONDRIAL RESPIRATION; NONHUMAN; SWINE;

ANIMALS; ARTERIES; CARBON RADIOISOTOPES; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME INHIBITORS; FATTY ACIDS; GLYCINE; LIPID METABOLISM; MYOCARDIUM; OXIDATION-REDUCTION; SWINE; SWINE, MINIATURE;

EID: 20744453864     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.03.003     Document Type: Article

References (30)

1. D.R. Bielefeld, T.C. Vary, and J.R. Neely Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle J Mol Cell Cardiol 17 1985 619 625
2. P.M. Latipaa Energy-linked regulation of mitochondrial fatty acid oxidation in the isolated perfused rat heart J Mol Cell Cardiol 21 1989 765 771
3. S.V. Pande, and M.S. Murthy Carnitine-acylcarnitine translocase deficiency: implications in human pathology Biochim Biophys Acta 1226 3 1994 269 276
4. H.R. Scholte, I.E. Luyt-Houwen, and M.H. Vaandrager-Verduin The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failing mitochondria and cardiomyopathy Basic Res Cardiol 82 Suppl 1 1987 63 73
5. D.J. Paulson Carnitine deficiency-induced cardiomyopathy Mol Cell Biochem 180 1-2 1998 33 41
6. L.H. Opie Role of carnitine in fatty acid metabolism of normal and ischemic myocardium Am Heart J 97 1979 375 388
7. R. Lango, R.T. Smolenski, M. Narkiewics, J. Suchorzewska, and W. Lysiac-Szydlowska Influence of l-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass Cardiovasc Res 51 2001 21 29
8. G.D. Lopaschuk Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia Am J Cardiol 80 1997 11A 16A
9. K.A. Yamada, J. McHowat, G.X. Yan, K. Donahue, J. Peirick, and A.G. Kleber Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia Circ Res 74 1994 83 95
10. G.L. Bartels, W.J. Remme, and H.R. Scholte Acute myocardial ischemia induces cardiac carnitine release in man Eur Heart J 18 1997 84 90
11. G.D. Lopaschuk, C.A. Hansen, and J.R. Neely Fatty acid metabolism in hearts containing elevated levels of CoA Am J Physiol 250 1986 H351 H359
12. J.Y. Kong, and S.W. Rabkin Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin Am J Physiol 282 2002 H717 H725
13. R.A. Goldstein, M.S. Klein, M.J. Welch, and B.E. Sobel External assessment of myocardial metabolism with carbon-11-labeled palmitate in vivo J Nucl Med 21 1980 342 348
14. H.R. Schön, H.R. Schelbert, G. Robinsson, A. Najafi, S.-C. Huang, and H. Hansen C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. I: Kinetics of C-11 palmitic acid in normal myocardium Am Heart J 103 1982 532 547
15. S.R. Bergmann, C.J. Weinheimer, J. Markham, and P. Merrero Quantitation of myocardial fatty acid metabolism using PET J Nucl Med 37 1996 1723 1730
16. T.P. Stephens, A.J. Higgins, G.A. Cook, and R.A. Harris Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine Biochem J 227 2 1985 651 660
17. J. Bremer Carnitine - metabolism and functions Physiol Rev 63 1983 1420 1479
18. G.J. Van der Vusse, J.F.C. Glatz, H.C.G. Stam, and R.S. Reneman Fatty acid homeostasis in the normoxic and ischemic heart Physiol Rev 72 1992 881 940
19. C.S. Patlak, and R.G. Blasberg Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data: generalizations J Cereb Blood Flow Metab 5 1985 584 590
20. S.H. Nellis, A.J. Liedtke, and B. Renstrom Distribution of carbon flux within fatty acid utilization during myocardial ischemia and reperfusion Circ Res 69 1991 779 790
21. K.A.A. Fox, D.R. Abendschein, H.D. Ambos, B.E. Sobel, and S.R. Bergmann Efflux of metabolized an nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically Circ Res 57 1985 232 243
22. 2H substitution, for in vivo studies of myocardium using PET Nucl Med Biol 21 1994 1053 1065
23. S.R. Bergmann, P. Herrero, R. Sciacca, J.J. Hartman, P.J. Rubin, and K.T. Hickey Characterization of altered fatty acid metabolism in patients with inherited cardiomyopathy J Inherit Metab Dis 24 2001 657 674
24. 14C]acetate into lipid in the perfused rat heart J Mol Cell Cardiol 4 1972 213 228
25. P.J. Randle, P.J. England, and R.M. Denton Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in rat heart Circ Res 63 1988 628 634
26. 11C]acetate as tracer of cardiac oxidative metabolism Am J Physiol 266 1994 H1304 H1315
27. A.M. Kates, P. Herrero, C. Dence, P. Soto, M. Srinivasan, and D. Delano Impact of aging on substrate metabolism by the human heart J Am Coll Cardiol 41 2003 293 295
28. 14C]palmitate into rat brain Neurochem Res 19 1994 1217 1223
29. T. Arai, S. Wakabayashi, M.A. Channing, B.B. Dunn, M.G. Der, and J.M. Bell Incorporation of [1-carbon-11]palmitate in monkey brain using PET J Nucl Med 36 1995 2261 2267
30. 14C]palmitic acid targets neutral lipids in hearts of awake rats Lipids 35 2000 891 898